ANRO

Alto Neuroscience, Inc.

35.65 USD

Last updated Sep 4, 20:59 UTC

Yesterday HIGH

$37.36

Yesterday LOW

$35.91

52w HIGH

$37.43

52w LOW

$3.41

EPS

-0.65

PE

-54.85

Next Earnings

Nov 11, 2026

Overview News Unusual Options Flow Government Trades Fundamentals

Alto Neuroscience, Inc. stock is up 27.19% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 September’s closed higher than August. In the last 10 Unusual Options Trades, there were 10 PUTs. 67% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

21 Aug 15:40	15 Jan, 2027	22.50	PUT	80	3
21 Aug 15:41	15 Jan, 2027	25.00	PUT	100	2
21 Aug 15:41	15 Jan, 2027	25.00	PUT	100	2
21 Aug 15:42	16 Oct, 2026	25.00	PUT	100	56
21 Aug 15:43	16 Oct, 2026	30.00	PUT	100	50
21 Aug 15:43	16 Oct, 2026	30.00	PUT	100	50
21 Aug 15:44	18 Sep, 2026	30.00	PUT	100	12
21 Aug 15:46	16 Apr, 2027	30.00	PUT	100	0
21 Aug 15:58	16 Apr, 2027	25.00	PUT	100	0
21 Aug 15:58	16 Apr, 2027	25.00	PUT	100	0

Advanced Data Unlock

Avi Kapoor

Thu Apr 2, 2026

Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results

US stocks fall, Dow drops over 50 points, real estate shares rise, Acuity Inc. shares decline, Sky Quarry Inc. and Cocrystal Pharma Inc. shares increase.
Benzinga Newsdesk

Thu Apr 2, 2026

HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $50 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $50 price target.
Benzinga Newsdesk

Thu Apr 2, 2026

Jones Trading Maintains Buy on Alto Neuroscience, Lowers Price Target to $44

Jones Trading analyst Justin Walsh maintains Alto Neuroscience (NYSE:ANRO) with a Buy and lowers the price target from $49 to $44.
Benzinga Newsdesk

Thu Apr 2, 2026

Wedbush Maintains Neutral on Alto Neuroscience, Lowers Price Target to $21

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and lowers the price target from $22 to $21.
Avi Kapoor

Thu Apr 2, 2026

Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Dow futures down 400 points, Alto Neuroscience shares dip 13.6% after Phase 2 trial results, other stocks also falling in pre-market trading.
Benzinga Newsdesk

Thu Apr 2, 2026

Alto Neuroscience shares are trading lower after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.
Avi Kapoor

Thu Apr 2, 2026

Why Globalstar Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Amazon may acquire Globalstar Inc., shares soared in pre-market trading. Other gainers include Turbo Energy SA, Semilux International Ltd, Visionary Holdings Inc, and more. Losers are PMGC Holdings Inc, Boqii Holding Ltd, Generation Income Properties Inc, Neo-Concept International Grp Hldngs Ltd, and System1 Inc.
Benzinga Insights

Wed Apr 1, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Newsdesk

Wed Apr 1, 2026

Alto Neuroscience shares are trading lower after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.
Benzinga Newsdesk

Wed Apr 1, 2026

Alto Neuroscience Announces Topline Data From Phase 2 POC Clinical Trial Evaluating ALTO-101 For Treatment Of CIAS; ALTO-101 Did Not Achieve Statistical Significance On Primary EEG Or Cognitive Endpoints Versus Placebo

— In the proof-of-concept study, ALTO-101 did not achieve statistical significance on primary endpoint; signals observed across EEG measures including near-significant improvement in theta-ITC (p=0.052) —— Alto has

HC Wainwright & Co.

Mon Aug 17, 18:10

buy

confirm
Wedbush

Thu Aug 13, 14:51

hold

confirm
BTIG

Thu Aug 13, 12:11

buy

confirm

Advanced Data Unlock

LRCX $307.56 USD

MU $1,015.36 USD

TSLA $353.91 USD

DIA $532.33 USD

LULU $100.57 USD

NFLX $78.29 USD

PSKY $10.87 USD

SMCI $39.60 USD